But it has no K2 to help with that D3 metabolism
Currently in research and development are several small molecule nonpeptide oral GLP-1 agonists that have positive human research results
Clinical trials have demonstrated reductions in high-sensitivity C-reactive protein (hs-CRP) and other inflammatory biomarkers, though these effects may be mediated through weight reduction rather than direct anti-inflammatory action
Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD1)
Possible Side Effects Most side effects are mild and temporary: Gastrointestinal: nausea, vomiting, diarrhea, constipation, bloating, stomach discomfort Neurological: headache, dizziness Injection site reactions: redness, swelling, or mild pain Rare but serious: pancreatitis, gallbladder issues, thyroid changes, low blood sugar in diabetic patients Our team will guide you through dosing, administration, and monitoring to ensure your safety and comfort